MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice.

Abstract

This study investigated the effects of a single administration of 6-(4-methoxyphenyl)-5-methyl-3-pyridinyl-4-isoxazolo[4,5-c]pyridin-4(5H)-one (MMPIP), a negative allosteric modulator (NAM) of metabotropic glutamate receptor 7 (mGluR7), on pain and on affective and cognitive behavior in neuropathic mice. The activity of pyramidal neurons in the prelimbic cortex (PLC), which respond to stimulation of the basolateral amygdala (BLA) with either excitation or inhibition, was also investigated. The spared nerve injury (SNI) of the sciatic nerve induced, 14 days after surgery, thermal hyperalgesia and mechanical allodynia, reduced open-arm choice in the elevated plus-maze, increased time of immobility in the tail suspension, and increased digging and burying in the marble burying test. Cognitive performance was also significantly compromised in the SNI mice. Spared nerve injury induced phenotypic changes on pyramidal neurons of the PLC; excitatory responses increased, whereas inhibitory responses decreased after BLA stimulation. mGluR7 expression, mainly associated with vesicular glutamate transporter, increased in the hippocampus and decreased in the BLA, PLC, and dorsal raphe in SNI mice. MMPIP increased thermal and mechanical thresholds and open-arm choice. It reduced the immobility in the tail suspension test and the number of marbles buried and of digging events in the marble burying test. MMPIP also improved cognitive performance and restored the balance between excitatory and inhibitory responses of PLC neurons in SNI mice. 7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one, XAP044, another selective mGluR7 NAM, reproduced the effects of MMPIP on thermal hyperalgesia, mechanical allodynia, tail suspension, and marble burying test. Altogether, these findings show that mGluR7 NAMs reduce pain responses and affective/cognitive impairments in neuropathic pain conditions.

• Authors: Enza Palazzo, Rosaria Romano, Livio Luongo, Serena Boccella, Danilo De Gregorio, Maria Elvira Giordano, Francesca Rossi, Ida Marabese, Maria Antonietta Scafuro, Vito de Novellis, Sabatino Maione
• Journal: Pain (Pain) Vol. 156 Issue 6 Pg. 1060-1073 (Jun 2015) ISSN: 1872-6623 [Electronic] United States
• PMID: 25760470 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo(4,5-c)pyridin-4(5H)-one
• 7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one
• Chromones
• Excitatory Amino Acid Antagonists
• Pyridones

Topics

• Action Potentials (drug effects)
• Amygdala (physiopathology)
• Animals
• Chromones (pharmacology, therapeutic use)
• Cognition Disorders (drug therapy, etiology)
• Disease Models, Animal
• Evoked Potentials (drug effects)
• Excitatory Amino Acid Antagonists (therapeutic use)
• Functional Laterality
• Hindlimb Suspension (physiology)
• Hyperalgesia (drug therapy, etiology)
• Male
• Maze Learning (drug effects)
• Mice
• Mood Disorders (drug therapy, etiology)
• Neurons (drug effects, physiology)
• Pain Threshold (drug effects)
• Pyridones (therapeutic use)
• Recognition, Psychology (drug effects)
• Sciatica (complications, drug therapy, pathology)